Potential role of the antimicrobial peptide Tachyplesin III against multidrug-resistant P. aeruginosa and A. baumannii coinfection in an animal model

References

• Kang S-J, Park SJ, Mishig-Ochir T, Lee B-J. Antimicrobial peptides: therapeutic potentials. Expert Rev Anti Infect Ther. 2014;12(12):1477–1486. doi:10.1586/14787210.2014.97661325371141
   PubMed Web of Science ®Google Scholar
• Francis AM. The wages of sin: how the discovery of penicillin reshaped modern sexuality. Arch Sex Behav. 2013;42(1):5–13. doi:10.1007/s10508-012-0018-423054260
   PubMed Web of Science ®Google Scholar
• Laxminarayan R, Duse A, Wattal C, et al. Antibiotic resistance-the need for global solutions. Lancet Infect Dis. 2013;13(12):1057–1098. doi:10.1016/S1473-3099(13)70318-924252483
   PubMed Web of Science ®Google Scholar
• Liu C, Shan B, Qi J, Ma Y. Systemic responses of multidrug-resistant pseudomonas aeruginosa and acinetobacter baumannii following exposure to the antimicrobial peptide cathelicidin-BF imply multiple intracellular targets. Front Cell Infect Microbiol. 2017;7. doi:10.3389/fcimb.2017.00517
   Web of Science ®Google Scholar
• Lacy MK, Stryjewski ME, Wang W, et al. Telavancin hospital-acquired pneumonia trials: impact of Gram-negative infections and inadequate Gram-negative coverage on clinical efficacy and all-cause mortality. Clin Infect Dis. 2015;61(Suppl 2):S87–S93. doi:10.1093/cid/civ53626316562
   PubMed Web of Science ®Google Scholar
• Karlowsky JA, Draghi DC, Jones ME, Thornsberry C, Friedland IR, Sahm DF. Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001. Antimicrob Agents Chemother. 2003;47(5):1681–1688. doi:10.1128/aac.47.5.1681-1688.200312709340
   PubMed Web of Science ®Google Scholar
• Cohen TS, Hilliard JJ, Jones-Nelson O, et al. Staphylococcus aureus α toxin potentiates opportunistic bacterial lung infections. Sci Transl Med. 2016;8(329):329ra31–329ra31. doi:10.1126/scitranslmed.aad9922
   Web of Science ®Google Scholar
• Cai S, Qiao X, Feng L, et al. Python cathelicidin CATHPb1 protects against multidrug-resistant staphylococcal infections by antimicrobial-immunomodulatory duality. J Med Chem. 2018;61(5):2075–2086. doi:10.1021/acs.jmedchem.8b0003629466000
   PubMed Web of Science ®Google Scholar
• Liu C, Qi J, Shan B, Ma Y. Tachyplesin causes membrane instability that kills multidrug-resistant bacteria by inhibiting the 3-Ketoacyl carrier protein reductase FabG. Front Microbiol. 2018;9:825.29765362
   PubMed Web of Science ®Google Scholar
• Wu H, Ong ZY, Liu S, et al. Synthetic beta-sheet forming peptide amphiphiles for treatment of fungal keratitis. Biomaterials. 2015;43:44–49. doi:10.1016/j.biomaterials.2014.11.05225591960
   PubMed Web of Science ®Google Scholar
• Lacerda AF, Pelegrini PB, de Oliveira DM, Vasconcelos EA, Grossi-de-Sa MF. Anti-parasitic peptides from arthropods and their application in drug therapy. Front Microbiol. 2016;7:91. doi:10.3389/fmicb.2016.0009126903970
   PubMed Web of Science ®Google Scholar
• Luo X, Guo Y, Bao J, et al. Characterization and antivirus activities of a novel bovine IFN-omega24. Mol Immunol. 2015;66(2):357–363. doi:10.1016/j.molimm.2015.04.00925951414
   PubMed Web of Science ®Google Scholar
• Pan CY, Lin CN, Chiou MT, Yu CY, Chen JY, Chien CH. The antimicrobial peptide pardaxin exerts potent anti-tumor activity against canine perianal gland adenoma. Oncotarget. 2015;6(4):2290–2301. doi:10.18632/oncotarget.295925544775
   PubMedGoogle Scholar
• Karal MA, Alam JM, Takahashi T, Levadny V, Yamazaki M. Stretch-activated pore of the antimicrobial peptide, magainin 2. Langmuir. 2015;31(11):3391–3401. doi:10.1021/la503318z25746858
   PubMed Web of Science ®Google Scholar
• Cirioni O, Simonetti O, Pierpaoli E, et al. Enhanced efficacy of combinations of pexiganan with colistin versus acinetobacter baumannii in experimental sepsis. Shock. 2016;46(2):219–225.26849630
   PubMed Web of Science ®Google Scholar
• Zhao L, Lu W. Defensins in innate immunity. Curr Opin Hematol. 2014;21(1):37–42. doi:10.1097/MOH.000000000000000524275690
   PubMed Web of Science ®Google Scholar
• Kuzmin DV, Emelianova AA, Kalashnikova MB, et al. Comparative in vitro study on cytotoxicity of recombinant beta-hairpin peptides. Chem Biol Drug Des. 2018;91(1):294–303. doi:10.1111/cbdd.1308128815904
   PubMed Web of Science ®Google Scholar
• Miyata T, Tokunaga F, Yoneya T, et al. Antimicrobial peptides, isolated from horseshoe crab hemocytes, tachyplesin II, and polyphemusins I and II: chemical structures and biological activity. J Biochem. 1989;106(4):663–668. doi:10.1093/oxfordjournals.jbchem.a1229132514185
   PubMed Web of Science ®Google Scholar
• Nakamura T, Furunaka H, Miyata T, et al. Tachyplesin, a class of antimicrobial peptide from the hemocytes of the horseshoe crab (Tachypleus tridentatus). Isolation and chemical structure. J Biol Chem. 1988;263(32):16709–16713.3141410
   PubMed Web of Science ®Google Scholar
• Katsu T, Nakao S, Iwanaga S. Mode of action of an antimicrobial peptide, tachyplesin I, on biomembranes. Biol Pharm Bull. 1993;16(2):178–181. doi:10.1248/bpb.16.1787689887
   PubMed Web of Science ®Google Scholar
• Yonezawa A, Kuwahara J, Fujii N, Sugiura Y. Binding of tachyplesin I to DNA revealed by footprinting analysis: significant contribution of secondary structure to DNA binding and implication for biological action. Biochemistry. 1992;31(11):2998–3004. doi:10.1021/bi00126a0221372516
   PubMed Web of Science ®Google Scholar
• Davidson DJ, Currie AJ, Reid GS, et al. The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J Immunol. 2004;172(2):1146–1156. doi:10.4049/jimmunol.172.2.114614707090
   PubMed Web of Science ®Google Scholar
• Cohen TS, Hilliard JJ, Jones-Nelson O, et al. Staphylococcus aureus alpha toxin potentiates opportunistic bacterial lung infections. Sci Transl Med. 2016;8(329):329ra31. doi:10.1126/scitranslmed.aaf0746
   Web of Science ®Google Scholar
• Shang D, Meng X, Zhang D, Kou Z. Antibacterial activity of chensinin-1b, a peptide with a random coil conformation, against multiple-drug-resistant Pseudomonas aeruginosa. Biochem Pharmacol. 2017;143:65–78. doi:10.1016/j.bcp.2017.07.01728756209
   PubMed Web of Science ®Google Scholar
• Camberlein E, Cohen JM, Jose R, et al. Importance of bacterial replication and alveolar macrophage-independent clearance mechanisms during early lung infection with Streptococcus pneumoniae. Infect Immun. 2015;83(3):1181–1189. doi:10.1128/IAI.02788-1425583525
   PubMed Web of Science ®Google Scholar
• Aloush V, Navon-Venezia S, Seigman-Igra Y, Cabili S, Carmeli Y. Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact. Antimicrob Agents Chemother. 2006;50(1):43–48. doi:10.1128/AAC.50.1.43-48.200616377665
   PubMed Web of Science ®Google Scholar
• Giles FJ, Rodriguez R, Weisdorf D, et al. A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy. Leuk Res. 2004;28(6):559–565. doi:10.1016/j.leukres.2003.10.02115120931
   PubMed Web of Science ®Google Scholar
• Bommarius B, Jenssen H, Elliott M, et al. Cost-effective expression and purification of antimicrobial and host defense peptides in Escherichia coli. Peptides. 2010;31(11):1957–1965. doi:10.1016/j.peptides.2010.08.00820713107
   PubMed Web of Science ®Google Scholar
• Tucker AT, Leonard SP, DuBois CD, et al. Discovery of next-generation antimicrobials through bacterial self-screening of surface-displayed peptide libraries. Cell. 2018;172(3):618–628.e13. doi:10.1016/j.cell.2017.12.00929307492
   PubMed Web of Science ®Google Scholar
• Lu Q, Luo R, Bodin L, et al. Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Anesthesiology. 2012;117(6):1335–1347. doi:10.1097/ALN.0b013e31827515de23132092
   PubMed Web of Science ®Google Scholar
• Korgaonkar A, Trivedi U, Rumbaugh KP, Whiteley M. Community surveillance enhances Pseudomonas aeruginosa virulence during polymicrobial infection. Proc Natl Acad Sci U S A. 2013;110(3):1059–1064. doi:10.1073/pnas.121455011023277552
   PubMed Web of Science ®Google Scholar
• Li S-A, Xiang Y, Wang Y-J, Liu J, Lee W-H, Zhang Y. Naturally occurring antimicrobial peptide OH-CATH30 selectively regulates the innate immune response to protect against sepsis. J Med Chem. 2013;56(22):9136–9145. doi:10.1021/jm401134n24151910
   PubMed Web of Science ®Google Scholar
• Liu CB, Shan B, Bai HM, Tang J, Yan LZ, Ma YB. Hydrophilic/hydrophobic characters of antimicrobial peptides derived from animals and their effects on multidrug resistant clinical isolates. Zool Res. 2015;36(1):41–47. doi:10.13918/j.issn.2095-8137.2015.1.4125730460
   PubMedGoogle Scholar
• Jones MCYG, Romela IR, Hebroni F, Seema BP, Caiyun X, Lloyd SM. Neutrophil-derived IL-1b is sufficient for abscess formation in immunity against Staphylococcu aureus in mice. Plos Pathogen. 2012;8(11):e1003047. doi:10.1371/journal.ppat.100304723209417
   PubMed Web of Science ®Google Scholar
• Liu CB, Qi JL, Shan B, et al. Pretreatment with cathelicidin-BF ameliorates Pseudomonas aeruginosa pneumonia in mice by enhancing NETosis and the autophagy of recruited neutrophils and macrophages. Int Immunopharmacol 2018;65:382–391. doi:10.1016/j.intimp.2018.10.030
   Web of Science ®Google Scholar
• Wan M, van der Does AM, Tang X, Lindbom L, Agerberth B, Haeggström JZ. Antimicrobial peptide LL-37 promotes bacterial phagocytosis by human macrophages. J Leukoc Biol. 2014;95(6):971–981. doi:10.1189/jlb.051330424550523
   PubMed Web of Science ®Google Scholar